BACKGROUND: Neurocognitive impairment (NCI) remains an important complication in persons infected with human immunodeficiency virus (HIV). Ancestry-related mitochondrial DNA (mtDNA) haplogroups have been associated with outcomes of HIV infection and combination antiretroviral therapy (CART), and with neurodegenerative diseases. We hypothesize that mtDNA haplogroups are associated with NCI in HIV-infected adults and performed a genetic association study in the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort. METHODS: CHARTER is an observational study of ambulatory HIV-infected adults. Haplogroups were assigned using mtDNA sequence, and principal components were derived from ancestry-informative nuclear DNA variants. Outcomes were cross-sectional global deficit score (GDS) as a continuous measure, GDS impairment (GDS ≥ 0.50), and HIV-associated neurocognitive disorder (HAND) using international criteria. Multivariable models were adjusted for comorbidity status (incidental vs contributing), current CART, plasma HIV RNA, reading ability, and CD4 cell nadir. RESULTS: Haplogroups were available from 1027 persons; median age 43 years, median CD4 nadir 178 cells/mm(3), 72% on CART, and 46% with HAND. The 102 (9.9%) persons of genetically determined admixed Hispanic ancestry had more impairment by GDS or HAND than persons of European or African ancestry (P < .001 for all). In multivariate models including persons of admixed Hispanic ancestry, those with haplogroup B had lower GDS (β = -0.34; P = .008) and less GDS impairment (odds ratio = 0.16; 95% confidence interval, .04, .63; P = .009) than other haplogroups. There were no significant haplogroup associations among persons of European or African ancestry. CONCLUSIONS: In these mostly CART-treated persons, mtDNA haplogroup B was associated with less NCI among persons of genetically determined Hispanic ancestry. mtDNA variation may represent an ancestry-specific factor influencing NCI in HIV-infected persons.
BACKGROUND: Neurocognitive impairment (NCI) remains an important complication in persons infected with human immunodeficiency virus (HIV). Ancestry-related mitochondrial DNA (mtDNA) haplogroups have been associated with outcomes of HIV infection and combination antiretroviral therapy (CART), and with neurodegenerative diseases. We hypothesize that mtDNA haplogroups are associated with NCI in HIV-infected adults and performed a genetic association study in the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort. METHODS: CHARTER is an observational study of ambulatory HIV-infected adults. Haplogroups were assigned using mtDNA sequence, and principal components were derived from ancestry-informative nuclear DNA variants. Outcomes were cross-sectional global deficit score (GDS) as a continuous measure, GDS impairment (GDS ≥ 0.50), and HIV-associated neurocognitive disorder (HAND) using international criteria. Multivariable models were adjusted for comorbidity status (incidental vs contributing), current CART, plasma HIV RNA, reading ability, and CD4 cell nadir. RESULTS: Haplogroups were available from 1027 persons; median age 43 years, median CD4 nadir 178 cells/mm(3), 72% on CART, and 46% with HAND. The 102 (9.9%) persons of genetically determined admixed Hispanic ancestry had more impairment by GDS or HAND than persons of European or African ancestry (P < .001 for all). In multivariate models including persons of admixed Hispanic ancestry, those with haplogroup B had lower GDS (β = -0.34; P = .008) and less GDS impairment (odds ratio = 0.16; 95% confidence interval, .04, .63; P = .009) than other haplogroups. There were no significant haplogroup associations among persons of European or African ancestry. CONCLUSIONS: In these mostly CART-treated persons, mtDNA haplogroup B was associated with less NCI among persons of genetically determined Hispanic ancestry. mtDNA variation may represent an ancestry-specific factor influencing NCI in HIV-infected persons.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Kaitlin B Casaletto; Anya Umlauf; Jennifer Beaumont; Richard Gershon; Jerry Slotkin; Natacha Akshoomoff; Robert K Heaton Journal: J Int Neuropsychol Soc Date: 2015-06-01 Impact factor: 2.892
Authors: R P van Rij; P Portegies; T Hallaby; J M Lange; J Visser; A M de Roda Husman; A B van 't Wout; H Schuitemaker Journal: J Infect Dis Date: 1999-09 Impact factor: 5.226
Authors: Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton Journal: Neurology Date: 2014-05-09 Impact factor: 9.910
Authors: Todd Hulgan; Asha R Kallianpur; Yan Guo; Jill S Barnholtz-Sloan; Haley Gittleman; Todd T Brown; Ronald Ellis; Scott Letendre; Robert K Heaton; David C Samuels Journal: J Acquir Immune Defic Syndr Date: 2019-04-01 Impact factor: 3.731
Authors: S Smieszek; P Jia; D C Samuels; Z Zhao; J Barnholtz-Sloan; H Kaur; S Letendre; R Ellis; D R Franklin; T Hulgan; A Kallianpur; W S Bush Journal: Mitochondrion Date: 2018-07-17 Impact factor: 4.160
Authors: Jerel Adam Fields; Brian Spencer; Mary Swinton; Emma Martine Qvale; María J Marquine; Arina Alexeeva; Sarah Gough; Benchawanna Soontornniyomkij; Elvira Valera; Eliezer Masliah; Cristian L Achim; Paula Desplats Journal: J Neurochem Date: 2018-11-26 Impact factor: 5.372
Authors: Peilin Jia; Zhongming Zhao; Todd Hulgan; William S Bush; David C Samuels; Cinnamon S Bloss; Robert K Heaton; Ronald J Ellis; Nicholas Schork; Christina M Marra; Ann C Collier; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; David M Simpson; J Allen McCutchan; Jill S Barnholtz-Sloan; Donald R Franklin; Debralee Rosario; Scott L Letendre; Igor Grant; Asha R Kallianpur Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-04-26 Impact factor: 3.568
Authors: Asha R Kallianpur; Quan Wang; Peilin Jia; Todd Hulgan; Zhongming Zhao; Scott L Letendre; Ronald J Ellis; Robert K Heaton; Donald R Franklin; Jill Barnholtz-Sloan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant Journal: J Infect Dis Date: 2015-12-21 Impact factor: 5.226
Authors: Sarah A Cooley; Robert H Paul; Christine Fennema-Notestine; Erin E Morgan; Florin Vaida; Qianqian Deng; Jie Ashley Chen; Scott Letendre; Ronald Ellis; David B Clifford; Christina M Marra; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; David M Simpson; Susan Morgello; Igor Grant; Beau M Ances Journal: J Neurovirol Date: 2016-03-28 Impact factor: 2.643
Authors: Andrew J Levine; Virawudh Soontornniyomkij; Eliezer Masliah; Janet S Sinsheimer; Sarah S Ji; Steve Horvath; Elyse J Singer; Asha Kallianpur; David J Moore Journal: J Neurovirol Date: 2020-05-11 Impact factor: 2.643
Authors: Kristine M Erlandson; Yuki Bradford; David C Samuels; Todd T Brown; Jing Sun; Kunling Wu; Katherine Tassiopoulos; Marylyn D Ritchie; David W Haas; Todd Hulgan Journal: AIDS Res Hum Retroviruses Date: 2020-01-14 Impact factor: 2.205
Authors: Karen Volpe; David Samuels; Asha Kallianpur; Ronald Ellis; Donald Franklin; Scott Letendre; Robert K Heaton; Todd Hulgan Journal: J Neurovirol Date: 2021-06-08 Impact factor: 3.739
Authors: A R Kallianpur; H Gittleman; S Letendre; R Ellis; J S Barnholtz-Sloan; W S Bush; R Heaton; D C Samuels; D R Franklin; D Rosario-Cookson; D B Clifford; A C Collier; B Gelman; C M Marra; J C McArthur; J A McCutchan; S Morgello; I Grant; D Simpson; J R Connor; T Hulgan Journal: Mol Neurobiol Date: 2018-09-12 Impact factor: 5.682